REVOFIL™ PLUS

REVOFIL PLUS is a sub-touch dermal filler designed to correct moderately pronounced wrinkles, enhance lip contours, and improve facial volume. It is based on a unique blend of cross-linked hyaluronic acid (23 mg/mL) and proprietary bioactive peptides, delivering smoother, longer-lasting, and more stable results compared to conventional HA fillers.

Developed with a patented peptide-mediated crosslinking technology, REVOFIL PLUS combines both monophasic and biphasic gel properties, offering enhanced elasticity and sculpting capability. It inhibits hyaluronidase, resists oxidative degradation, and promotes the synthesis of collagen and endogenous HA—resulting in visible rejuvenation effects that can last up to 12 months.

• Ideal for nasolabial folds, lips, forehead, and marionette lines
  
• Improves skin firmness, volume, and facial harmony
• Backed by 99% satisfaction rate in clinical studies

REVOFIL PLUS is injected into the mid to deep dermis using a 27G 1/2” needle. The procedure is carried out by trained professionals under sterile conditions.

Key Features:

• Designed for moderate-to-deep wrinkles and lip volumization
  
• Provides natural results with minimal discomfort
  

Protocol Details:

• Needle size: 27G 1/2”
  
• Injection depth: Mid to deep dermis
  
• Target areas: Nasolabial folds, lips, cheeks, jawline, forehead
  
• Syringe volume: 1 mL per unit
  
• Implant duration: Average 12 months before touch-up

REVOFIL PLUS is indicated for the treatment of moderate to deep facial wrinkles, including lip augmentation, and contouring of facial volume in the midface and lower face.

Indications:

• Correction of moderately deep wrinkles
  
• Enhancement of lip shape and volume
  
• Harmonization of facial contours
  
• Treatment of nasolabial folds, marionette lines, and jawline
  

Contraindications:

• Known allergy to hyaluronic acid
  
• Active infections or inflammation at the injection site
  
• Patients with autoimmune disorders
  
• Use during pregnancy or breastfeeding
  

Possible Side Effects:

• Redness or swelling at the injection site
  
• Bruising or tenderness
  
• Rare: Lumps or delayed inflammatory responses

REVOFIL PLUS is composed of cross-linked hyaluronic acid and a dual-peptide complex that enhances longevity, boosts collagen synthesis, and improves skin structure.

• Hyaluronic Acid (HA): 23 mg/mL, cross-linked, non-animal origin
  
• Oligopeptide-72 (CG-Boostrin): Inhibits hyaluronidase activity
  
• Oligopeptide-50 (CG-Glamerin): Stimulates collagen and HA production
  
• Gel type: Homogeneous, monophasic-biphasic hybrid
  

This combination ensures higher stability, soft injection, and improved tissue integration.

Each unit of REVOFIL PLUS is safely packaged to maintain sterility and quality control.

• 1 mL prefilled syringe of REVOFIL PLUS
  
• Sterile 27G 1/2” needle
  
• Blister pack for hygienic storage
  
• Instruction leaflet for professional use
  

All components are sealed to comply with medical safety regulations.

REVOFIL PLUS has a strong clinical safety profile with minimal adverse reactions. Side effects are typically mild and resolve spontaneously.

Common Side Effects:

• Localized redness
  
• Mild swelling or bruising
  
• Temporary tenderness
  

Rare Side Effects:

• Formation of nodules or small lumps
  
• Delayed hypersensitivity responses
  
• Discoloration or firmness at injection site
  

In a clinical study of 172 patients, 99% reported satisfaction with no significant allergic reactions.

To ensure product efficacy, REVOFIL PLUS must be stored under specific temperature and light conditions.

• Storage temperature: 2–25°C (36–77°F)
  
• Do not freeze
  
• Protect from direct sunlight
  
• Use before the expiration date on the packaging
  
• Once opened, use immediately and discard any remaining product